11:51 AM EST - ProMetic Life Sciences Inc. : Has initiated the rolling submission of its Biologics License Application for plasminogen with the U.S. FDA for treatment of patients with plasminogen congenital deficiency. ProMetic Life Sciences Inc.
shares T.PLI are trading up $0.28 at $1.84.
